Answers are grounded in this paper and cite their sources.
Clinical review reveals the spectrum of gestational diabetes and fetal morbidity risks in pregnant women, highlighting the need to balance detection and overtreatment.
Gestational diabetes mellitus is defined as glucose intolerance that is first detected during pregnancy.1 This simple definition belies the complexity of a condition that spans a spectrum of glycemia, pathophysiology, and clinical effects and for which there is a wide diversity of opinion regarding detection and clinical management. There is convincing evidence that mild maternal hyperglycemia is a risk factor for fetal morbidity,2 but that morbidity occurs only in a minority of cases. Failure to recognize and treat the condition will result in unnecessary morbidity in some pregnancies, whereas overly aggressive approaches to detection and treatment will result in unneeded . . .
No takes yet. Share an insight, caveat, or question.
Thomas A. Buchanan (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: